M. Zeng, et al.
Archives of Biochemistry and Biophysics 690 (2020) 108506
UV, IR, 1D and 2D NMR, and HR-ESI-MS. The absolute configurations
of A1 and D2 were established by the comparison of the experimental
and calculated electronic circular dichroism (ECD) spectra. In addition,
we also investigated the protective effects of A1 and D2 from Huai Flos
chrysanthemum on the LPS-induced injury in H9c2 cardiomyocytes, in
order to evaluate its effectiveness to protect the cardiomyocyte injury.
Table 1
NMR spectral data of compounds 1 (A1) and 2 (D2).
No.
δ
H
δ
C
A1
D2
A1
D2
1
2
3
4
5
6
7
8
9
135.6
104.8
154.4
139.5
154.4
104.8
87.3
136.8
107.5
149.4
148.6
109.0
120.6
87.0
6.70 (1H, s)
6.87 (1H, d, 2.0)
6.77 (1H, d, 8.0)
6.83 (1H, dd, 2.0, 8.0)
4.70 (1H, d, 5.0)
3.10 (1H, m)
2. Materials and methods
6.70 (1H, s)
4.70 (1H, d, 5.0)
3.10 (1H, m)
4.25 (1H, m)
55.7
72.9
55.5
72.7
2.1. General experimental procedures
4.23 (1H, m)
3
.86 (1H, m)
3.86 (1H, m)
NMR spectra (including 1D and 2D) were recorded at room tem-
1′
2′
3′
4′
136.5
107.5
149.4
148.6
109.0
120.6
87.2
137.7
111.6
150.1
147.7
118.1
119.8
87.3
perature (approximately 20–25 °C) on a Bruker Avance III 500 MHz
6.87 (1H, d, 2.0)
7.01 (1H, d, 2.0)
1
spectrometer using TMS as a standard (500 MHz for H NMR and
1
3
1
25 MHz for C NMR). ECD spectra were obtained on a Chirascanq CD
5
6
′
′
6.77 (1H, d, 8.0)
6.84 (1H, dd, 2.0, 8.0)
4.75 (1H, d, 5.0)
3.10 (1H, m)
4.25 (1H, m)
3
4.80 (1H, d, 8.0)
3.46 (1H, m)
3.40 (1H, m)
3.40 (1H, m)
3.18 (1H, m)
7.13 (1H, d, 8.0)
6.90 (1H, dd, 2.0, 8.0)
4.74 (1H, d, 5.0)
3.10 (1H, m)
4.23 (1H, m)
3.86 (1H, m)
4.87 (1H, d, 7.0)
3.47 (1H, m)
3.38 (1H, m)
3.38 (1H, m)
3.38 (1H, m)
spectrometer (Applied Photophysics) at room temperature. Optical ro-
tation was analyzed using the APIV (Rudolph Research Analytical). IR
spectrometry was performed using Nicolet iS10 Microscope
Spectrometer (Thermo Fisher Scientific). HR-ESI-MS spectra were ob-
tained on a Brukerma Xis HD mass spectrometer. UV spectra were ob-
tained on a Shimadzu UV-2401PC apparatus. Preparative HPLC was
conducted using a Saipuruisi LC-50 instrument with a UV200 detector
and YMC-Pack ODS-A column (250 × 20 mm, 5 μm and 250 × 10 mm,
μm). Column chromatography was performed using a Diaion HP-20
Mitsubishi Chemical Corporation), Toyopearl HW-40, MCI gel CHP-20
TOSOH Corporation), Sephadex LH-20 (Amersham Pharmacia Biotech
AB), LiChroprep RP-18 gel (Merck, Darmstadt) and silica gel (Marine
Chemical Industry). TLC was performed using self-made silica gel G
plates (Qingdao Marine Chemical Industry). All chemical reagents were
supplied by Beijing Chemical Plant, China and Tianjin NO. 3 Reagent
Plant, China.
7′
8
9
′
′
55.5
72.8
55.6
72.7
.86 (1H, m)
1″
105.3
75.7
78.3
71.3
77.8
62.6
102.8
74.9
78.2
71.3
77.8
62.6
2″
3″
4″
5″
6″
5
(
(
3.80 (1H, dd, 2.0, 12.0)
3
3.85 (6H, s)
5.92 (2H, s)
3.80 (1H, dd, 2.0, 12.0)
3.65 (1H, dd, 7.0, 12.0)
3.86 (3H, s)
.65 (1H, dd, 7.0, 12.0)
2 × OCH
OCH
3
57.1
102.4
55.5
102.4
-
2
-
5.92 (2H, s)
2
.4. Acid hydrolysis
Compound 1 (1 mg) was treated with 2 mol/L aqueous HCl (2 mL)
sealed flask, heating in water bath, 80 °C, 3 h). Then the acidic aqueous
(
mixture was dried, water (2 mL) was added, and the mixture was ex-
tracted with EtOAc (3 × 2 mL). The aqueous layer was subjected to the
chiral-phase HPLC analysis under the following conditions: The car-
bohydrate products of the hydrolysis of 1 was separated and detected
using a CHIRALPAK AD-H column (250 × 4.6 mm) using n-hexane:
EtOH: TFA (750:250:0.25) as the mobile phase (0.5 mL min ) using an
evaporative light scattering detector (ELSD). D-Glucose was detected in
the acid hydrolysates of compound 1 by comparing the retention times
2
.2. Plant materials
Dendranthema morifolium (Ramat.) S. Kitam was collected from the
Jiaozuo, Henan Province, China, in 2015, and identified by Prof. Sui-
qing Chen (Henan University of Chinese Medicine). A voucher spe-
cimen (No. 20150715A) was deposited in the Research Department of
Natural Medicinal Chemistry, School of Pharmacy, Henan University of
Chinese Medicine.
−
1
of their derivatives with those of known D-glucose derivatives (t
R
,
18.3 min) prepared in the same manner. Glucose samples for compar-
ison were procured from Shanghai Yuanye Biotechnology Co., Ltd.,
China.
2.3. Extraction and isolation
The plant Chrysanthemum morifolium Ramat (11.2 Kg) was extracted
2
.5. Cell culture and treatment
using 50% acetone (25 L × 3) thrice in a flash extractor at room
temperature (25 °C). The filtered solution was concentrated under re-
duced pressure to give an extract (2.5 kg). The extract was concentrated
further, under reduced pressure to give brown syrup, which was added
with water (9 L) and extracted successively by partitioning with pet-
roleum ether (5 × 3 L), EtOAc (5 × 104 L), and n-BuOH (5 × 4 L); the
extracts were kept separately. The EtOAc-soluble fraction (352.0 g) was
passed through a silica gel (1.0 Kg) open column (30 cm × 16 cm i.d.)
The H9c2 cardiomyocytes were obtained from the American Type
Culture Collection (Manassas, VA, USA). The cells were cultured in
DMEM at 37 °C under a humidified atmosphere of 5% CO2 in air. Heat
inactivated FBS (10%) and antibiotics penicillin/streptomycin (1%)
were included in the culture. H9c2 cells were seeded on 96-well plates
(
5000 cells/well, 100 μL) and allowed to adhere overnight. Then, the
cells were divided into the control group, model group (LPS 20 μg/mL,
Sigma, USA), compound 1 group (10 μM, LPS 20 μg/mL) and compound
2
eluted with CH
:1, 30L) to provide fractions A–D on the basis of TLC analysis. Fraction
C (31.0 g) was separated on silica gel CC again, eluting with CH Cl
MeOH (80:1, 60:1, 40:1, 20:1, 10:1, and 5:1), to obtain fractions C1-C6.
Fraction C4 was separated by MCI using gradient elution (100% H O to
0% MeOH) to give seven fractions (Fr.C4a−Fr.C4g) based on TLC
analysis. Fr.C4f was subjected to Sephadex LH-20 CC by eluting with
MeOH: H O (70:30) to afford Fr.C4f1 and Fr.C4f2. Fr.C4f2 was further
purified by RP-C18 HPLC [YMC-Pack ODS-AA, CH CN-H O (23:77, v/
v) containing 0.2% TFA] to afford compound 1 (t 62.0 min, 2.19 mg)
and 2 (t 57.3 min, 2.80 mg).
2 2
Cl /MeOH (v/v, 50:1, 30L→ 30:1, 30L →20:1, 30L →
5
group (10 μM, LPS 20 μg/mL). Twenty-four hours later, the cell
2
2
-
morphology was observed and the cell vitality was detected by the MTT
assay (Amresco, Seattle, United States). Real Time Cellular Analysis
2
(
[
RTCA, Acea Biosciences, Inc.) was used to calculate EC50 of A1 and D2
19].
4
2
3
2
2.6. Cytometric bead array (CBA) assay
R
R
The cell processing was performed in a similar manner as mentioned
2